Targeting the putative allosteric site J of cannabinoid receptor type 2 with peptide modulators: From mechanistic investigation to candidate identification
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
PANORAMA INTERNACIONAL DA PESQUISA SOBRE CANNABIS: AVANÇOS CIENTÍFICOS, DESAFIOS REGULATÓRIOS E PERSPECTIVAS PARA A SAÚDE E A INOVAÇÃO
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Clinical Trial: Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Multi-target molecular mechanisms underlying the protective effects of cannabidiol against methamphetamine-induced neurotoxicity.
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Psychiatric and substance use disorder polygenic scores are associated with the exposome in youth.
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Clinical characteristics of HHC-associated psychosis: an exploratory retrospective inpatient cohort study.
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Endocannabinoid system dysregulation in non-communicable diseases: implications for skeletal muscle health.
cannabis science digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Substance use, related harms and public health responses in Colombia: A national profile.
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Biomarker Evidence of Toxicant Exposure among Blunt and non-Blunt Cigar Smokers.
cannabis science digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Cannabinol β‑O-Glucoside Inhibitors of the Keap1-Nrf2 Interaction: A Novel Therapeutic Strategy for Parkinson’s Disease.
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
